AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 293: E1169-E1177, 2007. First published August 21, 2007; doi:10.1152/ajpendo.00263.2007
0193-1849/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
293/5/E1169    most recent
00263.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Didier, L.
Right arrow Articles by Gao, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Didier, L.
Right arrow Articles by Gao, J.

Diet-induced modulation of mitochondrial activity in rat muscle

Laurent Didier, Britttany Yerby, Richard Deacon, and Jiaping Gao

Discovery Technologies/Diabetes and Metabolism, Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts

Submitted 26 April 2007 ; accepted in final form 9 August 2007


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Growing evidence supports the theory that mitochondrial dysfunction is an underlying cause of intramyocellular lipid (IMCL) accumulation and insulin resistance. Here, we hypothesized that high dietary fat (HF) intake could trigger changes in mitochondrial activity such that fatty acid oxidation is impaired in muscle and contributes to an elevation in intramyocellular lipid (IMCL) levels. Muscle mitochondrial activity was determined in vivo through measurement of the F1F0 ATP synthase flux, the terminal step in the oxidative phosphorylation process. An initial study comparing rats on normal chow diet with rats on an HF diet revealed strong correlations between muscle ATP synthesis rates, IMCL levels and whole body glucose tolerance. Results obtained from two latter studies showed multiphasic responses to dietary intervention. Initially, the ATP synthesis rates decreased as much as 50% within 24 h of raising the fat content in the diet to 60% of the caloric intake. These rates eventually returned to normal values after 2–3 wk on the HF regimen, seemingly to prevent further IMCL accumulation. Only beyond 1 mo on the HF diet did results consistently show ATP synthesis rates to diminish by 30–50% accompanied by steadily augmenting IMCL levels. Interestingly, switching back to a chow diet after 3 wk of HF feeding reversed the initial diet-induced changes. Although the muscle mitochondrial system may initially offer enough compliance to counteract lipid surplus, these in vivo data suggest a vicious long-term cycle among mitochondrial dysfunction, IMCL accumulation, and glucose intolerance in the rat.

31P nuclear magnetic resonance spectroscopy; intramyocellular lipids; adenosine triphosphate synthesis; skeletal muscle; insulin resistance


THE IMPORTANCE OF FAT DISTRIBUTION in the etiology of insulin resistance, an early feature of type 2 diabetes, has been recognized for several decades. Not only do diabetic patients have a more centralized upper body fat pattern than nondiabetics, they also display elevated levels of intracellular fat in both skeletal muscles and the liver. Given that skeletal muscle is a major site of insulin resistance (skeletal muscle is responsible for ~80% glucose disposal) and the primary defect in the insulin-stimulated glucose transport pathway may be lipid related (3, 10, 20, 32, 37, 48), therapeutic strategies aimed at increasing fatty acid oxidation in the muscle present promising targets for future treatments of type 2 diabetes.

Mitochondrial oxidation of fatty acids and glucose accounts for the vast majority of ATP generation in healthy skeletal muscles. Not surprisingly, the bioenergetic capacity of skeletal muscle mitochondria is profoundly impaired in type 2 diabetic patients (18, 38, 41). In a perhaps less expected finding, recent clinical data obtained from both elderly patients (29) and offspring of parents with type 2 diabetes (26, 30) have also shown subtle and early defects in mitochondrial oxidative capacity (i.e., due to mitochondrial dysfunction and/or mitochondrial loss), which may lead to an accumulation of intracellular fatty acyl-CoA and harmful metabolites, such as diacylglycerol, that disrupt insulin signaling (16, 35). Furthermore, excess dietary fat may also play a crucial role in the development of mitochondrial dysfunction, as supported by a recent study showing downregulation of genes involved with oxidative phosphorylation and mitochondrial biogenesis in response to high-fat feeding (39).

Building upon these findings, it has been suggested that restoration of mitochondrial activity could help improve insulin sensitivity through enhanced fat oxidation. This type of treatment was shown to be effective on obese patients undergoing therapy involving physical activity (11, 24). Although divergent data occasionally suggest a dissociation between skeletal muscle adaptations and mitochondrial function (28), maximal enzyme activities do not necessarily reflect actual flux through metabolic pathways and consequently may not be sufficiently sensitive to detect the subtle changes in bioenergetic status. In addition, these studies rely on tissue biopsies to measure enzyme activities, allowing only a selected few time points, and often making longitudinal studies unfeasible.

Conversely, 31P magnetic resonance spectroscopy (MRS) provides a noninvasive means to monitor the energetic status of the cell by measuring intracellular phosphorylated metabolites [e.g., ATP and creatine phosphate (PCr)]. However, because of efficient regulation mechanisms, levels of energy metabolites in muscle under nonischemic and resting conditions frequently remain unchanged, making them insensitive indicators for the characterization of a pathological state. Accordingly, it is conceivable that a direct assessment of specific metabolic fluxes would offer a better alternative, with a dynamic range potentially wide enough for drug profiling studies. In this respect, 31P magnetization transfer offers the unique possibility to noninvasively determine certain reaction rates without disturbing the chemical equilibrium, as is often the case when labeled substrates are used. These qualities make this technique particularly effective in measuring reaction rates in vivo such as the one catalyzed by the mitochondrial F1F0 ATP synthase, the terminal step in the oxidative phosphorylation process. Since mitochondrial ATP production is coupled to substrate utilization via a stoichiometric relationship (40), it is reasonable to assume that any change in the ATP synthesis rate will reflect a change in oxidative phosphorylation.

In this context, the primary aim of this study was to investigate the existence of changes in mitochondrial activity that may occur in a diet-induced obesity rat model of insulin resistance. To do so, serial measurements were performed to 1) verify whether muscle ATP synthesis turnover is associated with other relevant markers of insulin resistance, specifically intracellular fat accumulation and glucose tolerance, 2) determine the conditions under which diet-induced changes in muscle ATP synthesis rate are readily reversible, and, finally, 3) assess the compliance of mitochondria in response to high lipid exposure during short-term and long-term high-fat diet regimens.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

All experiments were performed in male rats anesthetized with 2% isoflurane administered via a face mask during NMR data acquisition. Dietary interventions involved controlled modulation between normal chow diet (NC; 4.5% crude fat, Pico Lab Rodent Diet 20 no. 5053i; Lab Diet, Brentwood, MO) and high-fat diet (HF; diet no. D12492 [GenBank] , 60% fat cal; Research Diets, New Brunswick, NJ). All experimental procedures were carried out with the approval of the Novartis Institutional Animal Care and Use Committee.

Study Protocols

Study 1. In the initial study, the interactions between muscle ATP synthesis rates, whole body glucose tolerance, and intramyocellular lipid (IMCL) levels were investigated. To make these comparisons, six Sprague-Dawley rats were fed the HF diet for 10 wk, a situation known to induce peripheral insulin resistance, and were tested against six age-matched rats fed the NC diet.

Study 2. Another cohort of male Sprague-Dawley rats (n = 4) was repeatedly measured for ATP synthesis and IMCL levels while the diet was alternated from NC to HF for 3 wk (note this is less than the 8–10 wk typically accepted to induce insulin resistance) and then back to the NC diet. The main objective of this trial was to test the reversibility of short-term diet-induced changes in muscle mitochondrial function.

Study 3. In the final study, a detailed analysis of the relationship between mitochondrial function and fat storage was performed using ATP flux and IMCL measurements taken at relatively short intervals (i.e., every other day up to once a week) in a cohort of male Wistar rats (n = 6) fed the HF diet for 5 wk. The measurement of the ATP synthesis rate was systematically combined with the measurement of IMCL levels during the same NMR session.

Oral Glucose Tolerance Test

After overnight fasting (16 h), rats were given an oral bolus of glucose (1.0 g/kg), and blood samples were obtained via a tail nick 0, 30, 60, and 120 min after glucose administration. Blood samples (50 µl) were collected in heparinized microcentrifugation tubes (Brinkmann Instruments, Westbury, NY) and were centrifuged at 10,000 rpm for 5 min at 4°C. Plasma glucose concentrations and insulin levels were then measured using a YSI 2700 Dual Channel Biochemistry Analyzer (Yellow Springs Instrument, Yellow Springs, OH) and an ELISA assay kit (American Laboratory Products, Windham, NH), respectively.

The Matsuda insulin sensitivity index (ISI) was also calculated as a composite whole body ISI during the oral glucose tolerance test (OGTT) (ISI[composite]) using the following formula:

Formula 22(22)

In Vivo NMR Setup

All in vivo MR measurements were performed on a Bruker Avance 7.0 T/30 cm wide-bore instrument (Bruker Medical, Billerica, MA) equipped with 20-cm id actively shielded gradient insert. For each time point, two 13-min 31P saturation transfer spectra (i.e., ATP{gamma} saturated and unsaturated spectra), six 3.5-min 31P inversion recovery spectra (i.e., T1obs measurement) and one localized 1H-MR spectrum (i.e., IMCL measurement) were acquired. On average, total scan time did not exceed 1.5 h per animal. To collect signal from the lower leg of the rat, both 1H- and 31P-NMR spectroscopy were performed using a dual-frequency 1H/31P 2.5-cm surface coil working in a transmitter/receiver mode and tuned to 300.31 (1H) and 121.57 (31P) MHz.

IMCL measurement. IMCL contents were measured using a method similar to one presented earlier (19), but with acquisition parameters optimized for the 7T magnet. For each session, the rat was laid prone on a supportive bed, with the left leg positioned over the surface coil, and placed in the magnet isocenter. After global 1H shimming, transverse, sagittal, and coronal scout images (FISP: TE 1.82 ms, TR 3.64 ms, slice thickness 2 mm, field-of-view 35 x 35 mm, 8 averages) were acquired to confirm proper placement for 31P spectroscopic measurements and to carefully position the 2 x 2 x 2 mm3 volume of interest used to measure IMCL content in the left tibialis anterior (TA) muscle, avoiding blood vessels and gross adipose tissue deposits. Following 31P spectra collection, localized shimming was performed on the water signal to achieve typical line widths of ~13 Hz. The localized 1H-NMR spectrum was then collected using a PRESS sequence (TE 20 ms, TR 2 s, 4,096 data points over an 8-kHz spectral width, CHESS water suppression, 256 scans).

Measurement of muscle ATP synthesis rate. The unidirectional ATP production can be assessed noninvasively as initially described for measurements in Escherichia coli (6) and subsequently in the skeletal muscle in rat (5). In this procedure, the ATP{gamma} NMR peak is nulled with a saturating radio frequency (rf) pulse, and a reduction in the Pi peak is observed as a result of the transfer of the saturated spins between ATP{gamma} and the Pi pool (via the F1F0 ATPase reaction). In contrast to the heart, the glycolytic contribution to ATP synthesis [through e.g., glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 3-phosphoglycerate kinase reactions] can be considered negligible in skeletal muscles for which the Pi -> ATP flux is predominantly due to mitochondrial F1F0 ATPase activity (3).

Muscle ATP synthesis rates were measured in rats as previously reported by Jucker et al. (17). Two spectra were acquired for each saturation transfer experiment, one with and one without (control spectrum) steady-state saturation of the ATP{gamma} peak. The following acquisition parameters were used: nonselective detection of the intramyocellular 31P signal with a 90° block pulse, 10 kHz sweep width, and 1,024 data points, and selective irradiation of the ATP{gamma} resonance was achieved with a low-power continuous wave pulse applied for 5.9 s, a total of 128 averages, each with a 6-s repetition time. During acquisition of the control spectrum, the saturation pulse was placed at a frequency offset equidistant downfield of Pi. The ratio of the resulting magnetization (Mz) to the equilibrium magnetization (M0) in the absence of ATP{gamma} saturation is given by the equation:

Formula 1(1)
where k is the rate constant describing the loss of magnetization from Pi, and T1 is the longitudinal (spin-lattice) relaxation time for the Pi nucleus (17).

Despite the relatively fast reaction rate between Pi and ATP{gamma}, it is important that the spin-lattice relaxation time (i.e., observed T1obs) be evaluated on an individual basis in the presence of continuous ATP{gamma} saturation for accurate measurement. While applying an inversion recovery (IR) pulse during the mixing period, the apparent T1obs is related to T1 by the following equation:

Formula 2(2)

A 2,000-ms sech inversion pulse was applied at inversion delays (TI) of 299, 799, 1,749, 2,999, 4,499, and 5,999 ms from the 90° detection pulse to invert all Pi spins during the ATP{gamma} saturation and accurately determine T1obs for all Pi metabolites. Each IR spectrum was constituted of 32 averages, leading to a total experimental time of ~20 min. Typical results from an NC rat are summarized in Fig. 1. Individual T1obs values were calculated using a nonlinear least square fitting method based on the following equation:

Formula 3(3)


Figure 1
View larger version (12K):
[in this window]
[in a new window]

 
Fig. 1. Typical in vivo spectra from rat muscle obtained for the determination of the ATP synthesis rate by steady-state saturation transfer (A) and the spin-lattice relaxation time T1obs in the presence of continuous ATP{gamma} saturation (B). Arrows indicate the position for selective irradiation. The difference spectrum on the left was produced by subtraction of the ATP{gamma} saturated spectrum (Mz) from the control spectrum (M0). The inversion recovery (IR) delay was adjusted to yield optimal signal-to-noise ratio for the range of T1obs observed.

 
The decrease in Pi signal ({Delta}M) used to determine the kinetics of ATPase activity (i.e., the rate constant k) was computed by simultaneously solving Eqs. 1 and 2, yielding the following equation (17):

Formula 4(4)
where {Delta}M = M0Mz

The unidirectional ATP synthesis flux was then calculated by multiplying the constant k by the Pi concentration ([Pi]) extrapolated from the baseline NMR spectrum (comparing peak integrals from Pi and ATP{gamma}) and using concentrations ([ATP]) as obtained biochemically from calf muscles of 35 normal rats {i.e., [ATP] = 4.39 ± 0.53 µmol/g (2)}. Since changes in the {Delta}Pi signal contribute, for the most part, to changes in the calculated value of muscle ATP synthesis rate (i.e., only small variations in T1obs are expected), it was verified that any changes in the muscle ATP synthesis rate were actually matched with changes in corresponding {Delta}Pi/{Delta}ATP{gamma} ratios (results not shown).

Data Analysis

All 31P spectra were processed using XWIN NMR Suite (version 3.2; Bruker Biospin, Karlsruhe, Germany). After applying a 20-Hz line-broadening filter, phasing, and baseline correcting, peak areas were assessed for signals from Pi (4.9 ppm), PCr (0 ppm), and all three ATP (ATP{gamma}: –2.4, ATP{alpha}: –7.4, and ATPbeta: –15.9 ppm). To gain sensitivity in the saturation transfer experiment, the saturation-induced change in Pi peak area ({Delta}Pi) was assessed after subtracting the ATP{gamma} saturated spectrum from the unsaturated control spectrum. IMCL spectra were processed using the Nuts-PPC software package (Acorn NMR, Fremont, CA). Once spectra were line broadened, phased, and baseline corrected, peak areas for total creatine (tCr: 3.02 ppm), EMCLTA (methylene peak at 1.5 ppm), and IMCLTA (methylene peak at 1.3 ppm) were determined using a line-fitting procedure. IMCLTA content was then expressed as a percentage of tCr content.

Statistics

Where applicable, intergroup comparisons were made using a two-tailed, nonpaired Student's t-test or a two-way repeated-measures analysis of variance and simultaneous pairwise multiple comparison procedures (Holm-Sidak method). Data are presented as means ± SE, and P < 0.05 was considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Study 1: Relationships Between Muscle Mitochondrial Function and Whole Body Glucose Tolerance

Figure 2 displays the variations observed between a rat on the HF diet for 10 wk and an age-matched NC control. For each rat, the presented spectrum shows the difference observed between the unsaturated and the ATP{gamma}-saturated spectra. Although saturation of the ATP{gamma} peak was maximally effective in both cases, the loss of Pi signal was clearly greater for the NC rat than the rat fed the HF diet. Analysis of signal quality showed SNR values consistently in the range of 10–12 for rats fed an NC diet [using SNR = (2.5 x peak height)/peak-to-peak noise]. Assuming an SNR with a threshold value of 3 or greater for accurate measurement, this would theoretically give a dynamic range of ~75% for assessment of the muscle ATP synthesis flux between a nonpathological and a pathological model. For relatively constant Pi relaxation times (T1obs), this would translate into ATP synthesis flux values between ~3 and ~18 µmol·g–1·min–1. Ten weeks on the HF diet resulted in a ~35% decrease in ATP synthesis rate (Fig. 3). A positive linear correlation with a slope of ~1 with 10 ± 7% deviation from the mean was found during a test-retest study, indicating an excellent intraindividual reproducibility of ATP synthesis rate measurements (data not shown). Overall, actual rates obtained for muscle ATP synthesis in rats at rest are in excellent agreement with recent human data (36). After the 10-wk regimen, rats fed the HF diet also exhibited significantly higher body weights (data not shown) and IMCL levels (Fig. 3), supporting an obesity phenotype. At this time, an OGTT was also performed to determine whether the diet change triggered an insulin-resistant state. Areas under the curves (AUCs) for both glucose and insulin excursion data doubled (P < 0.05) in HF-fed rats relative to their NC-fed counterparts (Fig. 3), indicative of significant HF diet-induced glucose intolerance, a prediabetic condition. As expected, the HF diet also induced a significant impairment of whole body insulin sensitivity, as estimated under fasting by the Matsuda index (Fig. 3).


Figure 2
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 2. Typical 31P magnetization transfer difference spectra obtained from age-matched rats, one fed a normal chow diet (left) and the other one a high-fat (HF; right) diet for 4 wk. Area under the {Delta}Pi peak is much smaller for the HF-fed rat, likely indicative of a decrease in its muscle mitochondrial activity. Spectra were normalized to ATPbeta peak assuming muscle ATP concentrations were constant between rats.

 

Figure 3
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 3. Effect of a 10-wk HF diet on intramyocellular lipid (IMCL) levels and muscle ATP synthesis rates (A) and whole body glucose tolerance as measured from glucose and insulin excursions 120 min after an oral glucose load (OGTT; B). tCr, total creatine. Note that the the HF diet also induced significant impairment of whole body insulin sensitivity, as estimated under fasting conditions, by the Matsuda index. *P < 0.05, **P < 0.01, NC vs. HF diet.

 
Study 2: Effect of Diet Manipulation on Muscle ATP Synthesis

Figure 4 illustrates the time-course variations observed both in muscle ATP synthesis rates and in IMCL levels while the fat content in the diet was modulated. Upon induction of the HF diet, a drastic drop in mitochondrial activity was observed (~38% decrease in muscle ATP synthesis rate, P < 0.05). The changes in ATP synthesis rate measured after 5 days on the HF diet were accompanied by a sharp increase, almost fourfold, in IMCL storage. This change is likely to be a result of both an increased fatty acid uptake and decreased utilization (i.e., due to a defect in lipid oxidation). At day 21, the ATP flux appeared to return to normal values, and, even though dietary fat ingested remained elevated, IMCL stores were maintained at levels similar to those measured at day 5. Returning to the NC diet resulted in a rapid decline of IMCL contents (i.e., back to baseline levels in less than 2 days) without a concomitant change in muscle ATP synthesis rates. Two days later (day 25), the variables analyzed showed some divergence: muscle ATP synthesis drastically decreased by 27% while IMCL contents remained low. Also, no increase in body weight was observed during this 5-day transition period, suggesting that caloric intake was kept relatively low immediately after switching back to the NC diet (Fig. 4). This disconnect was only temporary, and within 2 wk the inverse relationship between the ATP synthesis rate and IMCL levels was again observed.


Figure 4
View larger version (15K):
[in this window]
[in a new window]

 
Fig. 4. Effects of diet manipulation on muscle ATP synthesis rate, IMCL levels, and body weights. ATP synthesis rate returned to normal values after 3 wk on the HF diet, which explains why synchronal IMCL contents did not increase at the same rate as observed 5 days after onset of the HF diet. The ATP synthesis rate displayed low values 4 days after switching back to the NC diet, as if mitochondrial activity had turned off while lipid availability (IMCL) was low. Such a discrepancy revealed itself a transient phenomenon, and the inverse relationship between ATP synthesis rates and IMCL levels could be observed again at a later time point (after 18 days on NC). *P < 0.05 vs. baseline (day –3), #P < 0.05 vs. after having switched back for 2 days to the NC diet.

 
Study 3: Short-Term vs. Long-Term Effects of HF Diet on the IMCL-ATP Synthesis Relationship

Here, we examined in more detail the time-course variations in muscle mitochondrial activity of rats on the HF diet for 5 wk. Unpublished in-house data demonstrate relative steadiness in muscle ATP synthesis rates and IMCL contents in rats on an NC diet up to 20 wk of age that were comparable to the baseline values measured in this study. Therefore, by comparing the time-course changes with the baseline values, each rat served as its own control, thus eliminating the need for comparisons with animals on an NC diet. Figure 5 shows a typical 1H spectrum series obtained in vivo from a single rat illustrating IMCL changes over the course of the study. Thanks to repeated measurements performed at relatively short time intervals, several phases in the response could be clearly identified during this period of altered diet both in terms of IMCL and muscle ATP synthesis rates (Fig. 6). After only 24 h on the HF diet (phase I), rats responded in an acute fashion with drastic lowering of the muscle ATP synthesis rate (–45%, P < 0.05 vs. baseline) and a concomitant increase in IMCL content (~3-fold, P < 0.05 vs. baseline). Beyond the first day (phase II), rats gradually regained mitochondrial activity while accumulating IMCL at a much slower pace, reaching maximum after 7 days (IMCL/tCr ratio of ~2.8, P < 0.05 vs. baseline). More succinctly, the increment in IMCL contents decreased as the ATP synthesis rate gradually returned toward baseline levels. During the subsequent 2 wk (phase III), both the ATP synthesis rate and IMCL contents remained constant, indicating the existence of a new metabolic steady state. This temporal equilibrium was characterized by an ATP flux slightly below the baseline value (~20%, not significant) in conjunction with relatively high IMCL levels. However, beyond 3 wk on the HF diet, the steady state gave way to a slow but stable decrease in muscle ATP synthesis rate with levels reaching ~60% of the baseline value at week 5 (P < 0.05). Concurrently (from weeks 3 to 5), IMCL contents regularly increased to levels six- to sevenfold greater than the baseline values. Body weight gain in these animals remained steady despite such variations (Fig. 6).


Figure 5
View larger version (18K):
[in this window]
[in a new window]

 
Fig. 5. Example of in vivo localized proton spectra series typically obtained from a male Wistar rat fed a 60% fat-enriched diet for 5 wk. Note the drastic increase in IMCL levels shortly after switching to the HF diet followed by an ~2-wk period with relatively constant IMCL levels. It is only after 3 wk on the HF diet that IMCL levels again increase.

 

Figure 6
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 6. Short- and long-term response to HF feeding in muscle ATP synthesis rates, IMCL levels, and body weights in male Wistar rats. Note the different phases (II, III, and IV) reflecting various metabolic states, phase I corresponding to the 24-h period after switching to the HF diet. Data obtained from study 1 (^) were added to the figure to show continuity, while time was scaled to maintain resolution of earlier measurements. Data are presented as means ± SE. *P < 0.05 vs. baseline; #P < 0.05 vs. 21 days.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The primary purpose of this work was to assess whether alterations in diet regimen influence muscle mitochondrial activity and whether those effects are associated with changes in lipid storage and whole body glucose tolerance. Although the data do not suggest causality, they do imply a direct association between these factors.

The diet-induced reduction in the rate of ATP synthesis fits nicely with a recent report (14), which showed a significant decrease in the respiratory capacity of the hindleg muscles from isolated mitochondria of adult rats under similar feeding conditions. Of note, these same authors had earlier revealed a completely contradictory picture in young rats (i.e., 30 days of age), in which high-fat feeding resulted in increased mitochondrial capacity to employ lipids as metabolic fuel (15). This parallels the accepted notion that adult rats are more prone to obesity than younger rats, which may benefit from adaptive thermogenesis to counteract diet-induced obesity (34). Whether high-fat feeding elicits a decline in the metabolic activity of adult rats through a decrease in mitochondrial mass and/or specific activit or by some other unknown meachnism, in a similar fashion to the aging process (1) remains to be determined.

Results obtained from the second experiment illustrated the high compliance of the mitochondrial system with variations in fat availability. The initially observed decrease in mitochondrial activity revealed itself to be transient, and consequently IMCL levels steadied as the ATP synthase flux rate recovered to baseline values. Speculatively, this may indicate that excessive fat storage can be temporarily barred by efficient oxidative phosphorylation despite augmented availability of circulating fat. This would imply that any new fatty acid entering the cell would be oxidized, preventing further lipid accumulation within the cell. This points to an adaptive mechanism that would allow the rat to still effectively counteract obesity at this time. This theory is in agreement with data showing significant increases in enzyme activity for fatty acid oxidation in muscles of adult rats maintained on a high-fat diet for 4 wk (27). As these should require time, one can speculate that the sharp rise in IMCL contents during this transition period results from both a lipid mass effect and a transient decrease in mitochondrial activity, the latter being directly or indirectly caused by inhibitory lipid intermediates. This may also partially explain why short-term consumption of a high-fat diet often results in only a mild impairment of whole body glucose tolerance, a defect likely to be hepatic in origin (9, 21). It also reconfirms the notion that, beyond the relative amount and nature of ingested fat (see example in Ref. 47), the length of the regimen obviously plays a crucial role as a dietary factor affecting the metabolic phenotype of muscle in a sustained fashion. Thus, depending on the model required, adult rats would need to be maintained on a high-fat diet for a minimum of 4 wk before showing clear signs of muscle insulin resistance (21).

The return to a normal chow diet prompted a rapid decline of IMCL contents, returning to baseline levels in less than 2 days, without concomitant change in muscle ATP synthesis rates. This supports the previous assertion that fully efficient oxidative phosphorylation attacks previously stored lipids (i.e., IMCL contents in the form of lipid droplets) as main substrates when new lipids entering muscle cells are scarce, thus returning the situation to one similar to that depicted under baseline conditions. However, 2 days later, the data showed some divergence: muscle ATP synthesis drastically decreased by 27% while IMCL contents remained low. One possible explanation is that mitochondrial activity temporally disconnects itself from lipid substrates by some unknown mechanism in times of short supply. As such, there was no change in body weight during the 5-day transition period, suggesting that caloric intake did not increase shortly after switching back to the normal chow diet. In other words, muscle fat oxidation decreased while lipids were, at that time, scarce as metabolic fuels. The lack of information on plasma glucose, insulin, and lipid profiles certainly limits our interpretation of these data, and additional studies would be needed to support such an assumption. However, one should note that this disconnect was only temporary, as within 2 wk the inverse relationship between the ATP synthesis rate and IMCL levels was again observed.

In our first experiment, the 10-wk HF regimen clearly resulted in an obesity phenotype, considering that IMCL contents almost doubled (P < 0.05) between 3 wk (IMCL/tCr = 3.45 ± 1.20) and 10 wk on the HF diet (IMCL/tCr = 6.44 ± 1.43). This could indicate a continuous "blunting" of ATP synthesis that resulted in a cumulative effect on intramyocellular fat accumulation. Our third experiment looked at periodic changes in the ATP synthesis flux in greater detail to help explore that hypothesis. Overall, the data obtained from this latter study support the possible existence of an intimate relationship between substrate (i.e., fat) availability and efficiency of utilization by the "burning factory" (i.e., muscle), as previously observed in healthy (4), prediabetic (30), and type 2 diabetic patients (36). Although the underlying molecular mechanism responsible for the initial inhibitory effect of intracellular lipids on oxidative phosphorylation remains to be elucidated, these results unambiguously demonstrate the capacity of the mitochondrial system to recover and preserve its function as long as ~3 wk with chronic exposure to high-fat food. These data are well aligned with previous results obtained from DIO (diet-induced obese) rodent models showing that at least one month on a high-fat diet is required to generate significant impairment in glucose tolerance (Ref. 13 and unpublished data), muscle insulin sensitivity (12), or muscle insulin signaling (31). This suggests an adaptive mechanism, which could, in part, explain why elevated dietary fat does not necessarily result in a drastic drop of oxidative enzyme activities (8, 42). It is possible that such a mechanism involves the mitochondrial uncoupling protein-3, which when induced under high-fat conditions (46) could protect mitochondria against lipid-induced oxidative damage (25) and help restore fatty acid oxidation to a normal level. However, this new equilibrium, which is usually not associated with insulin resistance in rats, appeared to be a transient phenomenon, since prolonging the high-fat diet beyond 3 wk resulted in a progressive degradation of muscle mitochondrial function and a steady increase in fat storage, as was recently shown (7). As suggested above, this latter transition phase may be associated with the appearance of an insulin resistance phenotype.

Assuming no change in physical activity, the fate of the extra ATP generated in response to an increase in mitochondrial activity (as observed for example during phase II in study 3) is unclear. Our hypothesis is that ATP production through nonoxidative glycolysis is decreased whereas proper mitochondrial activity is restored, which would preserve the balance between energy demand and supply. On the contrary, this pathway is not completely suppressed during insulin infusion in non-insulin-dependent diabetic patients (45). Such a hypothesis warrants further investigation.

To our knowledge, apart from indirect calorimetry, which is more global and provides little dynamic range, there is no gold standard against which the ATP synthesis rate measured by 31P saturation transfer can easily be validated. As mentioned earlier, maximal activity of the ATP synthase, which can only be determined in vitro, may not necessarily match with the actual flux measured in vivo. The same holds true for tricarboxylic acid cycle enzymes such as succinate dehydrogenase or citrate synthase. Since a reduction in mitochondrial density is associated with insulin resistance (26), one could consider measuring muscle cardiolipin, a known tissue marker of mitochondrial capacity, from tissue extracts (23, 43), except that the exact biological function of cardiolipin remains elusive. Conversely, muscle mitochondrial activity depends not only on the density and functionality of mitochondria but also on the supply of oxygen and substrate. In the present studies, ATP synthesis rate measurements were restricted to a resting state, i.e., dealing with basal metabolism. The fact that resting energy expenditure contributes to two-thirds of daily energy expenditure was the main justification for choosing this context. As a matter of fact, body weight regulation (and to some extent insulin resistance as well) mostly involves adjustment of the ratio of energy intake to resting energy expenditure, and as a result, fat balance is considered the main determinant of resting energy balance in obesity (44). Incorporating exercise into the assay to exacerbate this balance mechanism may help improve the dynamic range of the ATP turnover measurement. Such implementation, however, would require exercise to be performed under isometric conditions to minimize motion (and artifacts in the NMR spectrum) while maintaining strict control of the workload and tissue oxygenation (i.e., nonischemic exercise). Another possibility would be to test rats in response to an insulin challenge (clamp), which is known to enhance mitochondrial activity (4, 30).

In summary, these results demonstrate that mitochondrial activity is highly responsive to diet changes. Data showed a rapid reduction in ATP synthesis within a few days of raising fat in the diet. However, metabolic compliance in the rat muscle appears to be such that ATP synthesis can be restored and maintained at a normal rate up to 2–3 wk on the high-fat regimen, most likely to combat further accumulation of fat in skeletal muscles, this possible explanation being supported by our IMCL measurements. It is only beyond one month of exposure to high fat that a steady decrease in ATP synthesis rate is consistently observed. Although intergroup differences in ATP synthesis do not appear to be hindered by anesthesia, in vivo measurements using a combination of 31P saturation transfer and localized 1H-MRS may prove particularly useful for a better understanding of muscle insulin resistance, specifically the recent notion (33) of the vicious cycle that seems to exist between excessive fat storage in the muscle and a decrease in mitochondrial activity. Although the underlying mechanism that could explain how high lipid availability can change the rate of muscle ATP synthesis still warrants further investigation, these data may help define a novel readout and appropriate conditions to test mitochondrial activity as a therapeutic target for new antidiabetic drugs.


    FOOTNOTES
 

Address for reprint requests and other correspondence: D. Laurent, 250 Mass. Ave., Cambridge, MA 02139 (email: didier.laurent{at}novartis.com)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ames BN, Shigenaga MK, Hagen TN. Mitochondrial decay in aging. Biochim Biophys Acta 1271: 165–170, 1995.[Medline]
  2. Authier B, Albrand JP, Decorps M, Reutenauer H, Rossi A. Disruption of muscle energy metabolism due to intense ischaemic exercise: a 31P NMR study in rats. Physiol Chem Phys Med NMR 19: 83–93, 1987.[Web of Science][Medline]
  3. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438–2446, 1994.[Web of Science][Medline]
  4. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55: 136–140, 2006.[Abstract/Free Full Text]
  5. Brindle KM, Blackledge MJ, Challis RA, Radda GK. 31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo. Biochemistry 28: 4887–4893, 1989.[CrossRef][Medline]
  6. Brown TR, Ugurbil K, Shulman RG. 31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc Natl Acad Sci USA 74: 5551–5553, 1977.[Abstract/Free Full Text]
  7. Chanséaume E, Tardy AL, Salles J, Giraudet C, Rousset P, Tissandier A, Boirie Y, Morio B. Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. Obesity 15: 50–59, 2007.[Web of Science][Medline]
  8. Cheng B, Karamizrak O, Noakes TD, Dennis SC, Lambert EV. Time course of the effects of a high-fat diet and voluntary exercise on muscle enzyme activity in Long-Evans rats. Physiol Behav 61: 701–705, 1997.[CrossRef][Medline]
  9. Chisholm KW, O'Dea K. Effect of short-term consumption of a high fat diet on glucose tolerance and insulin sensitivity in the rat. J Nutr Sci Vitaminol (Tokyo) 33: 377–390, 1987.[Medline]
  10. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline G, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253–259, 1999.[Web of Science][Medline]
  11. Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52: 2191–2197, 1982.[CrossRef]
  12. Heijboer AC, Voshol PJ, Donga E, van Eden CG, Havekes LM, Romijn JA, Pijl H, Corssmit EPM. High fat diet induced hepatic insulin resistance is not related to changes in hypothalamic mRNA expression of NPY, AgRP, POMC and CART in mice. Peptides 26: 2554–2558, 2005.[CrossRef][Web of Science][Medline]
  13. Holeman K, Caluwaerts S, Poston L, Andre Van Assche F. Diet-induced obesity in the rat: a model for gestational diabetes mellitus. Am J Obstet Gynecol 190: 858–865, 2004.[CrossRef][Web of Science][Medline]
  14. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Botta M, Barletta A, Liverini G. Effect of high-fat feeding on metabolic efficiency, and mitochondrial oxidative capacity in adult rats. Br J Nutr 90: 953–960, 2003.[CrossRef][Web of Science][Medline]
  15. Iossa S, Mollica MP, Lionetti L, Crescenzo R, Botta M, Liverini G. Skeletal muscle oxidative capacity in rats fed high-fat diet. Int J Obes Relat Metab Disord 26: 65–72, 2002.[CrossRef][Web of Science][Medline]
  16. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005–2011, 2002.
  17. Jucker BM, Ren J, Dufour S, Cao X, Previs SF, Cadman KS, Shulman GI. 13C/31P NMR assessment of mitochondrial energy coupling in skeletal muscle of awake fed and fasted rats. J Biol Chem 275: 39279–39286, 2000.[Abstract/Free Full Text]
  18. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944–2950, 2002.[Abstract/Free Full Text]
  19. Korach-André M, Gao J, Gounarides J, Deacon R, Islam A, Laurent D. Relationship between visceral adiposity and intramyocellular lipid content in two models of insulin resistance. Am J Physiol Endocrinol Metab 288: E106–E116, 2005.[Abstract/Free Full Text]
  20. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397–1403, 1991.[Abstract]
  21. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 109, Suppl 2: S189–S201, 2001.[CrossRef][Web of Science][Medline]
  22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462–1470, 1999.[Abstract/Free Full Text]
  23. McMillin JB, Dowhan W. Cardiolipin and apoptosis. Biochim Biophys Acta 1585: 97–107, 2002.[Medline]
  24. Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288: E818–E825, 2005.[Abstract/Free Full Text]
  25. Minnaard R, Schrauwen P, Schaart G, Hesselink MK. UCP3 in muscle wasting, a role in modulating lipotoxicity? FEBS Lett 580: 5172–5176, 2006.[CrossRef][Web of Science][Medline]
  26. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, Pypaert M, Shulman GI. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115: 3587–3593, 2005.[CrossRef][Web of Science][Medline]
  27. Nemeth PM, Rosser BW, Choksi RM, Norris BJ, Baker KM. Metabolic response to a high-fat diet in neonatal and adult rat muscle. Am J Physiol Cell Physiol 262: C282–C286, 1992.[Abstract/Free Full Text]
  28. Ostergard T, Andersen JL, Nyholm B, Lund S, Nair KS, Saltin B, Schimtz O. Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 290: E998–E1005, 2006.[Abstract/Free Full Text]
  29. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140–1142, 2003.[Abstract/Free Full Text]
  30. Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2: e233, 2005.[CrossRef][Medline]
  31. Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Höer NF, Boschero AC, Abdalla Saad MJ. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146: 1576–1587, 2005.[Abstract/Free Full Text]
  32. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859–2865, 1996.[Web of Science][Medline]
  33. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 29, Suppl 2: S111–S115, 2005.[CrossRef]
  34. Rothwell NJ, Stock MJ. Energy expenditure of ‘cafeteria’-fed rats determined from measurements of energy balance and indirect calorimetry. J Physiol 328: 371–377, 1982.[Abstract/Free Full Text]
  35. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202–24210, 1999.[Abstract/Free Full Text]
  36. Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, Krssak M, Nowotny P, Wolzt M, Waldhausl W, Roden M. Muscle Mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PloS Med 4: e154, 2007.[CrossRef][Medline]
  37. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171–176, 2000.[Web of Science][Medline]
  38. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83: 166–171, 1997.[Abstract/Free Full Text]
  39. Sparks LM, Xie Hui Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54: 1926–1933, 2005.[Abstract/Free Full Text]
  40. Stryer L. Biochemistry. New York: Freeman, 1995, p. 507–558.
  41. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100: 7996–8001, 2003.[Abstract/Free Full Text]
  42. Suwa M, Kumagai S, Higaki Y, Nakamura T, Katsuta S. Dietary obesity-resistance and muscle oxidative enzyme activities of the fast-twitch fibre dominant rat. Int J Obes Relat Metab Disord 26: 830–837, 2002.[CrossRef][Web of Science][Medline]
  43. Takahashi M, Hood DA. Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol 74: 934–941, 1993.[Abstract/Free Full Text]
  44. Tounian P, Dumas C, Veinberg F, Girardet JP. Resting energy expenditure and substrate utilisation rate in children with constitutional leanness or obesity. Clin Nutr 22: 353–357, 2003.[CrossRef][Web of Science][Medline]
  45. Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38: 326–336, 1995.[Web of Science][Medline]
  46. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47: 298–302, 1998.[Abstract]
  47. Yakubu F, Lin D, Peters JC, Reed GW, Hill JO. Insulin action is influenced by amount and composition of dietary fat. Obes Res 1: 481–488, 1993.[Medline]
  48. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230–50236, 2002.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Laurent
Reply to Kemp: a clarification on the interpretation of muscular ATP synthase flux data obtained by 31P saturation transfer
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E643 - E644.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. J. Kemp
The interpretation of abnormal 31P magnetic resonance saturation transfer measurements of Pi/ATP exchange in insulin-resistant skeletal muscle
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E640 - E642.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
293/5/E1169    most recent
00263.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Didier, L.
Right arrow Articles by Gao, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Didier, L.
Right arrow Articles by Gao, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.